Loading organizations...
Loading organizations...
Biotech company developing therapeutic antibody fragments for diseases.
Delenex Therapeutics has raised $41.2M across 3 funding rounds.
Delenex Therapeutics has raised $41.2M in total across 3 funding rounds.
Delenex Therapeutics has raised $41.2M in total across 3 funding rounds.
Delenex Therapeutics's investors include BioMedPartners, HBM Partners, Novo Holdings, SV Health Investors, Venture Incubator, Thomas Dyrberg, HBM Healthcare Investments, VI Partners.
Delenex Therapeutics has raised $41.2M across 3 funding rounds. Most recently, it raised $8.0M Series A Extension in November 2013.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 6, 2013 | $8.0M Series A Extension | BioMedPartners, HBM Partners, Novo Holdings, SV Health Investors, Venture Incubator | |
| May 3, 2011 | $19.4M Series A Extension | Thomas Dyrberg | BioMedPartners, HBM Healthcare Investments, SV Health Investors, VI Partners |
| Nov 12, 2010 | $13.8M Series A | BioMedPartners, HBM Healthcare Investments, SV Health Investors, VI Partners |